EW Healthcare Partners Acquires Germfree Laboratories, Inc.
October 18, 2022
EW Healthcare Partners has acquired Germfree Laboratories, Inc., a US manufacturer of turnkey, mobile and modular cleanrooms, biocontainment facilities, and related biosafety equipment and services. The investment will support Germfree’s growth into advanced therapy manufacturing (cell and gene therapy) and help scale its manufacturing capacity from its Ormond Beach, Florida facility with nearly 200 employees.
- Buyers
- EW Healthcare Partners
- Targets
- Germfree Laboratories, Inc.
- Industry
- Medical Devices
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Germfree Laboratories Acquires Arcoplast
October 14, 2024
Building Products
Germfree Laboratories, a modular and mobile cleanroom equipment provider backed by EW Healthcare Partners, has acquired Arcoplast, a maker of seamless primary barrier cleanroom wall and ceiling systems. The deal expands Germfree’s capabilities into fixed-facility and turnkey cleanroom construction, broadening its offering across biopharma, hospital pharmacy, biocontainment and food & beverage end markets.
-
EW GROUP Acquires Hygiena from Warburg Pincus
February 16, 2021
Medical Devices
EW GROUP, a German strategic holding company, has agreed to acquire Hygiena, a Camarillo, California–based developer and manufacturer of food safety and environmental diagnostic solutions, from private equity firm Warburg Pincus. The deal, announced February 16, 2021, brings Hygiena together with EW GROUP’s diagnostic businesses (including BioChek and Biotecon) to expand molecular, veterinary and environmental testing capabilities and accelerate global growth.
-
Ampersand Capital Partners Invests in Genezen Laboratories
January 5, 2021
Biotechnology
Ampersand Capital Partners has made a majority growth-equity investment in Genezen Laboratories, a cell and gene therapy CDMO, to fund completion of a 25,000 sq. ft. cGMP lentiviral vector production facility and expand process development and analytical testing capabilities. The capital will support Genezen's capability expansion across upstream/downstream processing, analytical testing, and cGMP vector production to serve early‑phase and growth-stage cell and gene therapy developers.
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Heritage Global Partners Acquires American Laboratory Trading
August 23, 2021
Industrial Services
Heritage Global Partners (an affiliate of Heritage Global Inc.) acquired substantially all of the assets of American Laboratory Trading (ALT), a leading North American reseller of refurbished laboratory equipment. The deal includes ALT's building in East Lyme, Connecticut, and is intended to expand HGP's biotech and pharma services and New England footprint.
-
Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan
December 10, 2021
Healthcare Services
Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.